This might be a bit of a mess but I wanted to get this information out and I figure I can clean it up a bit later.
You might have noted that I keep adding on to the ethnic KPD list. You might have also noticed the strong representation of people of color in this list. It is tempting to think that there is some aspect of melanin involved in KPD but I seriously doubt it. I tend to see color as an indicator of certain things. The first thing it indicates is global location. Fairer people tend to live in more temperate climes. Darker skinned people tend to be located in more tropical regions.
What is it about those regions. One thing is parasites and malaria. It is known that genetic tests tend to show that people with protection against malaria also seem to have higher rates of kpd. I won’t go into the genetics but typically the same genes tend to be cited and they all tend to give an advantage in handling malaria. Here’s a listing of G6PD deficiency.
Table 1. Common Hemoglobinopathies: Populations Affected, Prevalence, and Outcomes |
Hemoglobin (Hb) Variant | Populations Affected | Prevalence (in the United States unless otherwise noted) | Outcome with One Abnormal Gene and One Normal Gene (Heterozygous State) | Outcome with Two Abnormal Genes (Homozygous State) |
Hemoglobin S (HbS) | African Americans Hispanic Americans/Latinos Also found in East India, the Mediterranean, and the Middle East | About one in 12 African Americans has sickle cell About one in 100 Hispanic Americans/Latinos has sickle cell Sickle cell anemia occurs in one of every 500 African American births 1 Sickle cell anemia occurs in one of every 1,000 to 1,400 Hispanic American/Latino births 1 | Sickle cell trait (also called HbAS): usually asymptomatic | Sickle cell anemia (also called HbSS disease): sickled red blood cells that interfere with circulation and decrease life span of red blood cells; can result in hemolytic, splenic sequestration, and aplastic crises and multiple complications |
Hemoglobin C (HbC) | African Americans People of West African descent | About 2.3 percent of African Americans have HbC trait 3 | HbC trait (also called HbAC): asymptomatic | HbC disease (also called HbCC disease): mild hemolytic anemia, mild to moderate enlargement of the spleen |
Hemoglobin E (HbE) | Asian Americans, especially those of Southeast Asian descent Common in Cambodia, Indonesia, Laos, Malaysia, Thailand, and Vietnam. Also seen in southern China, India, the Philippines, and Turkey | Prevalence of HbE may be 30 percent in Southeast | HbE trait (also called HbAE): asymptomatic | HbE disease (also called HbEE disease): mild hemolytic anemia, microcytosis, and mild enlargement of the spleen |
Hemoglobin SC (HbSC) | African Americans and people of West African descent Also found in East India, the Mediterranean, and the Middle East |
| N/A | HbSC disease (also called sickle-hemoglobin C disease): mild hemolytic anemia and moderate enlargement of the spleen; may have blocking of blood vessels as in sickle cell anemia but milder symptoms |
Hemoglobin F (HbF) elevated | Occurs in patients with hereditary persistence of fetal hemoglobin, sickle cell anemia, severe anemias, leukemia, and other conditions | About 1.5 percent have more than 2 percent HbF but some groups may have concentrations as high as 12 percent 3 | N/A | Those with elevated HbF and sickle cell anemia may have a milder form of sickle cell anemia |
2 National Human Genome Research Institute, NIH. Learning about sickle cell disease. Available at: www.genome.gov/10001219. Posted February 2007. Accessed July 3, 2007. 3 Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clinical Chemistry. 2001;47(2):153–163.
Unless you are totally blind, you will recognize that all this information matches up with who gets KPD. It also matches up with Malaria.
Now the reason for bringing this up is about the tendency of these issues to affect the A1c. They can cause an over estimation of A1c but most typically they will cause and under reading for A1c. This is because the A1c is a measure of glycation. (basically carmelized blood cells)This measure, however, assumes that the average blood cell will be around for 90 days. What if the cell has a shorter life as it tends to have with these two issues? The number for glycation is going to be lower simply because the blood cell hasn’t been around long enough to get glycated as much. The A1c will appear to be lower.
I have already written about the ADA, diabetes and the danger to KPD’s. This needs to be tossed in. We are in serious trouble with the ADA guidelines since they sit right at the point of DKA for us but what if the test is off? We shouldn’t be anywhere near an A1c of 6.3 for safety sake. The A1c number could be 5.8 but, in truth, we could be at 6.5, which is trouble.
Here is what that trouble means. It means a continual rise in DKA admissions to hospitals with all the attendant costs. As has been noted before, there isn’t any real way to separate out KPD’s from Type 2’s but the suspicion is that greater than 50% of new onset DKA admissions are KPD’s and for all we know a good many of the Type 2’s are KPD, as well.
DKA’s Admissions per year
This graph shows a doubling of admissions in the last 25 years, basically 60,000 more than 25 years ago and it is rising. KPD’s are probably a little better than half this number. If you add the blood glycation problem with the ADA recommendations you can see how this might be the case.
Things aren’t getting any better for us and they won't get better anytime soon because they are now going to make the A1c the diagnostic tool for diabetes. For us, this is a really really bad idea.
Posts
